Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01185002 · ClinicalTrials.gov registry record · Phase 2
Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen
A Phase 2 study of Colonoscopy and Endoscopy, sponsored by Medtronic - MITG.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 7
- Study locations
NCT01185002: Completed Phase 2 study of Colonoscopy and Endoscopy, sponsored by Medtronic - MITG.
NCT01185002 is a Phase 2 study of Colonoscopy and Endoscopy that has completed, run by Medtronic - MITG. The registered enrollment target is 80 participants, below the 498-participant average among 20 other Colonoscopy trials with a reported enrollment target (84% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01185002, a Phase 2 study of Colonoscopy and Endoscopy, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of the study is to test the effect of a bowel preparation and boosts regimen on PillCam® procedure, colon cleanliness and capsule excretion time.
Conditions Studied
Interventions
- OTHER PillCam® COLON 2 procedure using MgC boosts
- OTHER PillCam® COLON 2 procedure using Suprep boosts
- OTHER PillCam® COLON 2 procedure using reduced dose of Suprep boosts
Study Locations (7)
Alabama
- Alabama Digestive Disorders Center - Huntsville
Indiana
- Division of Gastroenterology Indiana University Medical Center - Indianapolis
New York
- Research Associates of New York - New York
North Carolina
- University of North Carolina Division of Digestive Disease - Chapel Hill
Ohio
- Digestive Care, Inc. - Beavercreek
Tennessee
- Franklin Gastroenterology - Franklin
Virginia
- Gastroenterology Associates of Tidewater - Chesapeake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
What the finished NCT01185002 record still lists
NCT01185002 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 498-participant average among 20 other Colonoscopy trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Colonoscopy appearing as the primary indexed condition, and to 3 interventions - of which PillCam® COLON 2 procedure using MgC boosts is the first listed.
NCT01185002 lists 7 locations in 7 states (Alabama, Indiana, New York).
Frequently Asked Questions
What is clinical trial NCT01185002 about?
NCT01185002 is a clinical study titled "Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen". The purpose of the study is to test the effect of a bowel preparation and boosts regimen on PillCam® procedure, colon cleanliness and capsule excretion time.
What is the current status of trial NCT01185002?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2010-07. Estimated completion is 2011-06.
What conditions does trial NCT01185002 study?
This clinical trial studies the following conditions: Colonoscopy, Endoscopy.
What interventions are being tested in trial NCT01185002?
The interventions under investigation include: PillCam® COLON 2 procedure using MgC boosts (OTHER), PillCam® COLON 2 procedure using Suprep boosts (OTHER), PillCam® COLON 2 procedure using reduced dose of Suprep boosts (OTHER).
Who is sponsoring clinical trial NCT01185002?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01185002 being conducted?
This trial has 7 study locations across Alabama, Indiana, New York, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01185002's enrollment target sits among peer trials
80 20th of 20 higher than 1 of 20 other Colonoscopy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colonoscopy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as a Preparation for Colonoscopy in Adults
COMPLETED · Phase 2
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
RECRUITING
-
Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study
RECRUITING
-
Impact of Artificial Intelligence on Trainee Polyp Miss Rates
RECRUITING · NA
-
Cold Snare Endoscopic Mucosal Resection Trial
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia